Your browser doesn't support javascript.
loading
A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
Shi, Tingyan; Yin, Sheng; Zhu, Jianqing; Zhang, Ping; Liu, Jihong; Zhu, Yaping; Wu, Sufang; Chen, Xiaojun; Wang, Xipeng; Teng, Yincheng; Zhu, Tao; Yu, Aijun; Zhang, Yingli; Feng, Yanling; Huang, He; Bao, Wei; Li, Yanli; Jiang, Wei; Zhang, Ping; Li, Jiarui; Ai, Zhihong; Zhang, Wei; Jia, Huixun; Zhang, Yuqin; Jiang, Rong; Zhang, Jiejie; Gao, Wen; Luan, Yuting; Zang, Rongyu.
Affiliation
  • Shi T; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China. tyshi80@163.com.
  • Yin S; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu J; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang P; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Liu J; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhu Y; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Wu S; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Chen X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Wang X; Department of Gynecology and Obstetrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Teng Y; Department of Gynecology and Obstetrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Zhu T; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Yu A; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang Y; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Feng Y; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Huang H; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Bao W; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Li Y; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Jiang W; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Zhang P; Department of Gynecology and Obstetrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li J; Department of Gynecology and Obstetrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ai Z; Department of Gynecology and Obstetrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Zhang W; Department of Biostatistics, Fudan University, Shanghai, China.
  • Jia H; Clinical Statistics Center, Shanghai General Hospital, Shanghai, China.
  • Zhang Y; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Jiang R; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang J; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Gao W; Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Luan Y; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zang R; Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
J Gynecol Oncol ; 31(3): e61, 2020 05.
Article in En | MEDLINE | ID: mdl-32319233
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Piperidines / Cytoreduction Surgical Procedures / Indazoles Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Female / Humans Country/Region as subject: Asia Language: En Journal: J Gynecol Oncol Year: 2020 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Piperidines / Cytoreduction Surgical Procedures / Indazoles Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Female / Humans Country/Region as subject: Asia Language: En Journal: J Gynecol Oncol Year: 2020 Type: Article Affiliation country: China